1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Influenza Vaccine Revenue Forecasts and R&D Outlook 2016-2026: Prospects for Technologies Including Trivalent and Quadrivalent Flu Shots

Influenza Vaccine Revenue Forecasts and R&D Outlook 2016-2026: Prospects for Technologies Including Trivalent and Quadrivalent Flu Shots

  • January 2016
  • -
  • Visiongain
  • -
  • 139 pages

Summary

Table of Contents

Please note: The license is valid for 12 months from the date the report is sent.


Report Details
Influenza Vaccines – Your 2016 Guide to Developments and Sales Potentials
Do you want to explore the future of vaccines against the influenza virus? If so, visiongain’s new report shows you trends, R&D, sales results, opportunities and revenue forecasts.

Avoid missing out. With our research and analysis you assess companies, technologies and products, benefiting your reputation for commercial insight.

Read on to explore the flu shots industry and see what revenue its market could generate in future.

Sales prospects of human flu preventions – our study shows you what is possible
Our new study gives revenue predictions at overall world, submarket, product and national levels. You gain discussions and expert opinion on vaccines protecting against influenza:
- Influenza vaccine revenues to 2026 – discover the overall potential of that market worldwide, seeing commercial opportunities and possibilities
- 2 submarkets’ revenues to 2026 – explore that industry’s segments at world level, finding the most lucrative and promising technologies and trends
- 6 revenue forecasts covering leading vaccine brands to 2026 – see how those anti-flu agents can compete and succeed, discovering their sales potentials
- 11 leading countries’ revenue forecasts to 2026 – investigate countries in the Americas, Europe and Asia, assessing prospects for influenza market expansion
- Analysis of leading companies and R&D pipelines for that preventive medicine – assess potentials of companies, seeing how they can compete and succeed
- Assessment of what stimulates and restrains that important healthcare market – analyse challenges, strengths and views, seeing how you can gain.

Forecasting of that world market, showing what is possible for those prophylactic medicines
In our 138 page report you receive 32 tables, 32 charts and an interview with a vaccine producer. Besides giving revenue predictions, our new analysis shows you recent results, business news, sales growth rates, market shares and R&D trends.

First our study gives revenue forecasts to 2026 for two influenza submarkets:
- Trivalent vaccines
- Quadrivalent vaccines.

With our report you investigate influenza vaccine development, manufacturing and selling. You also explore potential shifts in market shares from 2016 to 2026. See what leading companies do, assessing that industry’s potential.

Product forecasts – assess sales potentials of leading brands
Our new analysis also shows you predictions for leading flu vaccines, giving six revenue forecasts to 2026:
- Fluzone/Vaxigrip
- Afluria/Fluvax
- Fluarix/FluLaval
- FluMist/Fluenz
- Fluvirin/Flucelvax
- FluBlok.

With our investigation you assess business potentials for leading influenza vaccines. You also explore research and development. Discover what is possible from 2016, then, benefiting your influence and reputation for commercial insight.

National markets for influenza vaccine sales – what does the future hold?
Our study shows you prospects for influenza vaccine revenues in developed and developing countries. There see individual forecasts to 2026 for 11 countries:
- United States
- Japan
- Germany, France, United Kingdom, Italy and Spain (the EU5 group)
- Brazil, Russia, India and China (the BRIC group).

With our analysis you investigate countries with highest revenues, demand and potential sales growth. Explore progress, needs and opportunities, seeing how you can gain.

Forces affecting developers, producers and sellers of those healthcare products
Our report explains issues, trends, events and R&D from 2016, including these forces:
- Paediatric and adult influenza vaccines – present and future developments
- Advances in research and development, including vaccine delivery technology – assess innovations, progress and opportunities
- Deals in that industry, including the creation of Seqirus in July 2015
- Antigenic drift and shift – overcoming viral challenges to protect populations
- Seasonal influenza epidemics and pandemic outbreaks giving high demand.

Also explore the effects of these influences:
- Governments and international organisations’ roles in flu vaccination
- Supply and demand, including effects of healthcare providers and payers’ policies
- US healthcare reforms – benefits for vaccine sales
- Strengths, weaknesses, opportunities and threats, as well as social, technological, economic and political forces – examine what influences that industry
- Potential for universal flu vaccine to transform the market – see what is possible.

Worldwide revenues of influenza vaccines will reach $6.4 billion in 2018, our study predicts. Sales will rise from 2016 to 2026 as technological advances and rising demand give growth opportunities. With our analysis you see what the future holds and how you can benefit.

Influenza vaccines – who are the top companies?
From 2016, large pharmaceutical companies and other biopharma specialists can prosper in that important healthcare market. Discover how, seeing organisations’ potentials.

In particular our study explores these industry leaders:
- Sanofi Pasteur
- GSK
- Novartis
- AstraZeneca
- CSL and Seqirus
- Protein Sciences Corporation.

Gain predictions for influenza vaccines, getting information to help you stay ahead
With our independent study you assess products, companies, progress and potentials. Explore commercial opportunities and technological advances. Discover what is possible.

Having that information means you are less likely to fall behind in knowledge or miss opportunity. Through your choice now, find how to save time and effort, also benefiting your plans, decisions, presentations, proposals and influence.

Try our new study. That investigation shows you data, trends, opportunities and forecasts for that expanding vaccine market. So avoid missing out – please get our report here now.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
The Global Influenza Market

The Global Influenza Market

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Receive an overview of products currently in the marketplace and a detailed analysis of market position and competitive environments. - Identify the markets in general segments: ...

Influenza Diagnostics Market by Test type, Molecular, End user - Global Forecast to 2021

Influenza Diagnostics Market by Test type, Molecular, End user - Global Forecast to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global influenza diagnostics market is expected to reach USD 767.4 million by 2021 from USD 508.0 million in 2016, at a CAGR of 8.6% from 2016 to 2021. On the basis of test type, the market is segmented ...

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies

  • $ 4995
  • Industry report
  • January 2017
  • by GBI Research

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies Summary Seasonal influenza is a viral ...


Download Unlimited Documents from Trusted Public Sources

Influenza Statistics in Germany

  • April 2017
    11 pages
  • Influenza  

  • Germany  

    Europe  

View report >

Influenza Statistics in the UK, Weekly Update

  • April 2017
    11 pages
  • Influenza  

  • United Kingdom  

    Europe  

View report >

Global Influenza Statistics

  • April 2017
    17 pages
  • Influenza  

    Infectious Dise...  

  • World  

    Canada  

View report >

Related Market Segments :

Influenza

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.